Interferon-Regulated Chemokines as Biomarkers of Systemic Lupus Erythematosus Disease Activity: A Validation Study

Arthritis & Rheumatism
doi 10.1002/art.24803
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Biomarkers of Disease Activity and Organ Damage in Systemic Lupus Erythematosus

English

Interferon Alpha in Systemic Lupus Erythematosus

Journal of Biomedicine and Biotechnology
2010English

Defining Low Disease Activity in Systemic Lupus Erythematosus

Arthritis Care and Research
Rheumatology
2017English

Type I Interferon and Systemic Lupus Erythematosus

Journal of Interferon and Cytokine Research
MedicineVirologyImmunologyCell Biology
2011English

Is Low Disease Activity Good Enough as a Target in Systemic Lupus Erythematosus?

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Biomarkers for Systemic Lupus Erythematosus: An Update

International Journal of Clinical Rheumatology
Rheumatology
2015English

Mannose Binding Lectin: A Biomarker of Systemic Lupus Erythematosus Disease Activity

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2012English

Validation of the Systemic Lupus Erythematosus Activity Questionnaire in a Large Observational Cohort

Arthritis & Rheumatism
2008English

Association of Systemic Lupus Erythematosus Disease Activity Index Score With Clinical and Laboratory Parameters in Pediatric Onset Systemic Lupus Erythematosus

Pakistan Journal of Medical Sciences
Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy